150 related articles for article (PubMed ID: 37926895)
1. Thrombocytopenia Caused by Iron Infusion in a Patient with End-Stage Kidney Disease.
Bibi S; Naveed K; Haq A
J Coll Physicians Surg Pak; 2023 Nov; 33(11):1337. PubMed ID: 37926895
[TBL] [Abstract][Full Text] [Related]
2. Transient severe thrombocytopenia in a patient on CAPD after intravenous iron administration.
Taskapan H; Bahceci F; Taskapan C; Sahin I; Kaya E; Aydogdu I
Perit Dial Int; 2003; 23(4):408-9. PubMed ID: 12968855
[No Abstract] [Full Text] [Related]
3. Leukopenia and thrombocytopenia in hemodialysis patients with hepatitis B or C virus infection and non-hemodialysis patients with hepatitis cirrhosis.
Ng YY; Lin CC; Wu SC; Hwang SJ; Ho CH; Yang WC; Lee SD
Clin Nephrol; 2002 Apr; 57(4):289-95. PubMed ID: 12005245
[TBL] [Abstract][Full Text] [Related]
4. Epidemic of iron overload in dialysis population caused by intravenous iron products: a plea for moderation.
Vaziri ND
Am J Med; 2012 Oct; 125(10):951-2. PubMed ID: 22795817
[No Abstract] [Full Text] [Related]
5. Leucopenia in adult polycystic kidney disease patients on haemodialysis.
Banerjee A; Chandna S; Jayasena D; Farrington K
Nephron; 2002 May; 91(1):175-6. PubMed ID: 12021540
[No Abstract] [Full Text] [Related]
6. High frequency of linezolid-associated thrombocytopenia and anemia among patients with end-stage renal disease.
Wu VC; Wang YT; Wang CY; Tsai IJ; Wu KD; Hwang JJ; Hsueh PR
Clin Infect Dis; 2006 Jan; 42(1):66-72. PubMed ID: 16323094
[TBL] [Abstract][Full Text] [Related]
7. Intravenous iron: the iatrogenic kick to lose control over oxygen?
Deicher R; Hörl WH
Kidney Blood Press Res; 2002; 25(5):284-8. PubMed ID: 12435873
[TBL] [Abstract][Full Text] [Related]
8. Thrombocytopenia and anemia induced by niceritrol used for amelioration of hyperphosphatemia in a hemodialysis patient.
Wakasugi H; Futami T; Muso E; Ono T; Sasayama S; Inui K
Nephron; 2000 Sep; 86(1):97-8. PubMed ID: 10971163
[No Abstract] [Full Text] [Related]
9. Iron supplementation in renal anemia.
Fishbane S
Semin Nephrol; 2006 Jul; 26(4):319-24. PubMed ID: 16949471
[TBL] [Abstract][Full Text] [Related]
10. Thrombocytopenia in a Hemodialysis Patient Starting Home Therapy with NxStage System One: Management in a Community Setting.
Parmar MS
Saudi J Kidney Dis Transpl; 2021; 32(6):1775-1781. PubMed ID: 35946292
[TBL] [Abstract][Full Text] [Related]
11. Parenteral iron safety and the special article "Just the FAQs: frequently asked questions about iron and anemia in patients with chronic kidney disease".
Coyne DW
Am J Kidney Dis; 2002 Jul; 40(1):219-20. PubMed ID: 12087586
[No Abstract] [Full Text] [Related]
12. [Severity of acquired cystic kidney disease determines improvement in chronic kidney failure anemia].
Bezerra HM; Maia GP; Bezerra Neto FA; Serra M; de Almeida JB
Rev Assoc Med Bras (1992); 1997; 43(1):4-8. PubMed ID: 9224984
[TBL] [Abstract][Full Text] [Related]
13. The iron story: red smoke and magnetism?
Wish JB
Nephrol News Issues; 2014 Feb; 28(2):2-3. PubMed ID: 24649743
[No Abstract] [Full Text] [Related]
14. Clinical and economic outcomes in Medicare beneficiaries with stage 3 or stage 4 chronic kidney disease and anemia: the role of intravenous iron therapy.
Knight TG; Ryan K; Schaefer CP; D'Sylva L; Durden ED
J Manag Care Pharm; 2010 Oct; 16(8):605-15. PubMed ID: 20866165
[TBL] [Abstract][Full Text] [Related]
15. [Left ventricular hypertrophy in end-stage renal disease and its possible regression as a result of correction of anemia and arterial hypertension].
Dzgoeva FU; Gatagonova TM; Kadzaeva ZK; Khamitsaeva OV; Kochisova ZKh; Dzutseva AT; Bazaeva BG
Ter Arkh; 2011; 83(6):42-6. PubMed ID: 21786575
[TBL] [Abstract][Full Text] [Related]
16. Iron in the treatment of anemia in dialysis patients: an important support to erythropoietin.
Gallieni M
Int J Artif Organs; 1998 Nov; 21(11):681-6. PubMed ID: 9894741
[No Abstract] [Full Text] [Related]
17. [Treatment of anemia in renal failure].
Siciński A
Pol Tyg Lek; 1974 Nov; 29(44):1895-8. PubMed ID: 4610533
[No Abstract] [Full Text] [Related]
18. Treatment of anaemia in end-stage renal disease: A double-edged iron sword?
Chinnadurai R; Macdougall IC; Kalra PA
EBioMedicine; 2019 Feb; 40():31-32. PubMed ID: 30660656
[No Abstract] [Full Text] [Related]
19. Erythropoietin for end-stage renal disease.
Adamson JW; Eschbach JW
N Engl J Med; 1998 Aug; 339(9):625-7. PubMed ID: 9718384
[No Abstract] [Full Text] [Related]
20. [Treatment with high dose of intravenous iron increases mortality and hospitalization in hemodialysis].
Fernández-Gallego J; Martín Reyes G; Valera A; Toledo R
Nefrologia; 2004; 24(1):87-8. PubMed ID: 15083966
[No Abstract] [Full Text] [Related]
[Next] [New Search]
